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AbstrACt 
Objectives Potentially modifiable risk factors account 
for approximately 23% of breast cancers, with obesity 
and alcohol being the two greatest. Breast screening and 
symptomatic clinical attendances provide opportunities 
(‘teachable moments’) to link health promotion and breast 
cancer-prevention advice within established clinical 
pathways. This study explored knowledge and attitudes 
towards alcohol as a risk factor for breast cancer, and 
potential challenges inherent in incorporating advice about 
alcohol health risks into breast clinics and screening 
appointments.
Design A mixed-method study including a survey on risk 
factors for breast cancer and understanding of alcohol 
content. Survey results were explored in a series of five 
focus groups with women and eight semi-structured 
interviews with health professionals.
setting Women attending NHS Breast Screening 
Programme (NHSBSP) mammograms, symptomatic breast 
clinics and healthcare professionals in those settings.
Participants 205 women were recruited (102 NHSBSP 
attenders and 103 symptomatic breast clinic attenders) 
and 33 NHS Staff.
results Alcohol was identified as a breast cancer risk 
factor by 40/205 (19.5%) of attenders and 16/33 (48.5%) 
of staff. Overall 66.5% of attenders drank alcohol, and 
56.6% could not estimate correctly the alcohol content 
of any of four commonly consumed alcoholic drinks. 
All women agreed that including a prevention-focussed 
intervention would not reduce the likelihood of their 
attendance at screening mammograms or breast clinics. 
Qualitative data highlighted concerns in both women 
and staff of how to talk about alcohol and risk factors 
for breast cancer in a non-stigmatising way, as well as 
ambivalence from specialist staff as to their role in health 
promotion.
Conclusions Levels of alcohol health literacy and 
numeracy were low. Adding prevention interventions to 
screening and/or symptomatic clinics appears acceptable 
to attendees, highlighting the potential for using these 
opportunities as ‘teachable moments’. However, there are 
substantial cultural and systemic challenges to overcome 
if this is to be implemented successfully.
bACkgrOunD
Breast cancer is the most common cancer 
in the UK with >54 000 new cases diagnosed 
annually and the incidence is continuing 
to rise.1 Although cure rates are now high, 
breast cancer remains a significant public 
health problem and more than 11 000 women 
per year die of advanced disease.1 There is an 
urgent need to focus on developing popula-
tion-based prevention strategies to reduce the 
morbidity and mortality from breast cancer.2 
Alcohol use is now estimated to be respon-
sible for between 5% to 11% of breast cancer 
cases and current evidence suggests that it 
is a risk factor for all age groups.3 4 Alcohol 
increases the risk of breast cancer in a dose-de-
pendant fashion from low levels of consump-
tion5 6 and a positive association between 
alcohol consumption and breast cancer risk 
strengths and limitations of this study
 ► A mixed methodological approach enabled a broad-
er exploration of knowledge and attitudes to alcohol 
as a risk factor for breast cancer than  achievable 
using a single research method.
 ► Participants were women attending the NHS Breast 
Screening Programme (NHSBSP) mammograms, 
symptomatic breast clinics and healthcare profes-
sionals based in a single hospital, to understand how 
attitudes and information needs in this area may dif-
fer across these groups.
 ► Cross-sectional survey results were explored in a 
series of five focus groups with women and eight 
semi-structured interviews with health profession-
als, to enable triangulation of data.
 ► Research in this area is at an early stage, such that 
there are no standardised tools to measure the con-
structs explored.
 ► The study was conducted in a single UK centre, lim-
iting the potential generalisability of the results.
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has been supported by over 100 studies.7 Over 20% of 
women aged 45 to 64 reportedly drink more than 14 units 
per week,8 so any interventions to reduce population level 
consumption could have a significant influence on breast 
cancer rates,9 as well as help to manage the side-effects of 
treatment, and improve the overall health of survivors.10 11
Two important components for motivating and 
sustaining behaviour change are the awareness of the 
health risks (or benefits) of a behaviour, and one’s own 
risk level.12 13 Awareness of alcohol as a risk factor for 
breast cancer is low,14 as is the ability to estimate the 
alcohol content of commonly consumed drinks and there-
fore objectively assess one’s own alcohol consumption 
level.15 This suggests that many women may be unaware 
that their level of alcohol consumption may be increasing 
their risk of breast cancer.
Evidence for lifestyle advice interventions in breast 
cancer prevention is limited,16 but out-patient clinics for 
investigation of breast symptoms could constitute what 
has been called a ‘teachable moment’; these are defined 
as ‘naturally occurring health events thought to motivate 
individuals to spontaneously adopt risk-reducing health 
behaviours’.17 Initial research suggests this has high levels 
of acceptability with women coming for breast mammog-
raphy screening17 and provide an opportunity for deliv-
ering low-intensity interventions to a general population 
cohort, as already demonstrated in emergency depart-
ments and other healthcare settings.12 13
The NHS Breast Screening Programme (NHSBSP) 
provides free breast mammographic screening every 
3 years for all women aged 50 and over. In total, 
1.94 million women aged 45 and over were screened 
within the programme in England in 2011 to 2012 with a 
73.1% uptake of routine invitations.18 In addition, approx-
imately 230 000 women attend a symptomatic breast 
clinic each year in the UK.19 Early detection of cancers 
occurs in very small proportions (0.08% in the screening 
group,<8% in the symptomatic group are diagnosed with 
a breast cancer), therefore the vast majority of women 
who attend do not currently benefit individually from 
their attendance in prevention terms. This interaction 
provides an opportunity to reach a significant number 
of women, in a situational context where the motivation 
for behaviour change is enhanced, thereby improving the 
cost-benefit ratio of the current service.
Despite the positive potential of implementing interven-
tions in this setting, it is important to first understand how 
features of the breast health appointment context may 
influence the applicability - and acceptability to patients 
and staff - of any intervention.20 This study aimed to assess 
the acceptability, to female patients, and healthcare staff, 
of offering an alcohol brief intervention (ABI) in NHS 
clinical breast services. Our research questions were: (a) 
What level of knowledge do women and staff have about 
alcohol as a modifiable breast cancer risk? (b) What level 
of awareness of alcohol content in drinks do women and 
staff possess? (c) What are women’s perceptions and 
emotions in relation to alcohol and cancer risk? and (d) 
How acceptable would an alcohol brief intervention be to 
staff and women attending breast health appointments? 
These data will be used to inform the sample size for a 
definitive project as currently there are no published data 
on variability or effect sizes in relation to alcohol breast 
cancer awareness or risk factor knowledge.
MethODs
Design
This mixed-method study used quantitative data as the 
primary frame, with a secondary qualitative frame to 
build on the quantitative data. Outcomes of the analysis 
of cross-sectional survey data were used as prompts for 
focus group and telephone discussions.
Recruitment based on securing a minimum sample size 
of 100 for each clinical group and 20 staff members was 
determined to be plausible based on known attendance 
and staff numbers at Southampton breast services, and to 
be sufficient to generate data of risk factor and alcohol 
knowledge to be explored in depth within qualitative 
interviews.21
Staff interview questions about risk factors mirrored the 
survey questions and additionally explored meaning and 
emotional appraisal. Three focus groups consisting of a 
maximum of eight women each were planned, as eight is 
considered the optimum focus group number when the 
topic is of importance to participants.22 Women self-se-
lected and attended the group most convenient for them.
The study received approval from the NRES Committee 
South Central - Hampshire A Research Ethics Committee 
(reference no.14/SC/1399), and all participants gave 
informed consent.
Patient and public involvement
The design for this study was developed at an innova-
tion workshop funded jointly by Cancer Research UK 
(CRUK) and BUPA Foundation (a private healthcare 
charitable trust) which included patient and public 
involvement (PPI) representation. Following up the initial 
survey results with participants in a series of focus groups 
and telephone interviews ensured participants were 
actively involved in the conduct of the study. The data and 
preliminary findings were presented at a CRUK showcase 
event including a wide range of PPI stakeholders.
Participants
Participants were recruited from three different popu-
lations: (1) Women attending NHSBSP mammograms 
(SG), (2) women attending symptomatic breast clinics 
(CG) and (3) NHS health professionals associated with 
these services (HP). All participants meeting the eligi-
bility criteria for inclusion (over the age of 18) on the 
12 days the researcher (ES) was in the specified breast 
health services were approached, and those with sufficient 
English to give informed consent were recruited. Uptake 
rate was 82% in SG, 88% in CG and 71% in HP groups, 
suggesting limited bias in sampling. In the event five 
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focus groups were conducted with a total of 29 women. 
The smallest group size consisted of three women and 
the largest 11. All data were collected between January - 
July 2015. All patients provided written informed consent 
before completing the survey.
Quantitative data
As there are currently no psychometrically validated 
tools to measure knowledge of breast cancer risk factors 
or estimation of alcohol content in UK drinks, we devel-
oped our own questionnaire specifically for this study 
(see online supplementary appendix A). Participant 
demographic information was collected using stan-
dardised UK national statistics demographic categorisa-
tion. Based on the authors’ knowledge of the area and 
a scoping review of the literature, current known modi-
fiable and non-modifiable risk factors for breast cancer 
were identified and cross-referenced against risk factors 
reported on public information websites.23–25 Factors 
were classified as having convincing, probable, limited 
or no evidence. This provided a coding framework for 
survey responses (see online supplementary appendix 
B). Each free-text response listed by study participants 
in response to the question ‘write down anything you think 
might increase the risk of breast cancer’, was coded by ES, and 
10% of the responses were double-coded by JS to check 
consistency.
Self-reported height and weight were used to calcu-
late body mass index (BMI). Participants were given four 
multiple choice questions to identify the units of alcohol 
in four drink types (see online supplementary file A).
The phrase ‘We are interested to know your thoughts 
on the impact of adding specific cancer prevention infor-
mation to the breast cancer screening process.’ was used 
specifically rather than referring to alcohol education 
as we did not wish to influence participant’s response to 
other questions within the survey by highlighting alcohol 
(or obesity) as the two greatest potentially modifiable risk 
factors for breast cancer. Participants in each of the three 
groups completed the same survey to allow for compar-
ison across groups
Qualitative data
Women attending either a clinic or a mammography 
screening appointment who had taken part in the survey 
were invited (with the option to bring a female friend or 
relative) to a focus group ‘to discuss their opinion about some 
of the methods available to try and reduce the number of women 
who develop breast cancer’. The topic guides are available in 
online supplementary appendix C.
Health professionals, working in breast clinics or 
screening services, were also invited to take part in a 
semi-structured telephone interview to discuss some of 
the findings of the survey further. Interviews were by tele-
phone to reduce participant burden and maximise the 
degree of anonymity for participants to encourage frank 
and open responses.
Analysis
Clinic/mammogram attenders (CG and SG groups) 
reported their views of what may be acceptable and 
appropriate in terms of information about alcohol as a 
risk factor for breast cancer, delivered as an intervention 
embedded within NHS breast clinics (both symptomatic 
and preventative screening appointments).
After the clinic/mammogram attenders (CG and SG 
groups) and staff (HP group) data sets were analysed 
separately, they were compared with each other to deter-
mine where the staff and attendee views met and diverged, 
giving two sides of the same story.
Chi square tests assessed differences between the 
recruited groups in terms of demographical and health 
characteristics, risk factor identification and ability to 
identify alcohol units. Likelihood ratio tests comparing 
logistic regression models with and without interaction 
terms were used to assess if the association between risk 
factor identification and individual characteristics varied 
between groups. Analysis were conducted using Stata 
V.14.2.
Qualitative data from the focus groups and telephone 
interviews were transcribed verbatim, and then analysed 
using the principles of thematic analysis26 whereby themes 
emerging from the data are synthesised into initial cate-
gories. These initial categories were then discussed with 
the wider research team for identification of the most 
salient themes with reference to the overarching research 
question and linkage back to the quantitative survey data. 
During data collection and analysis there were discus-
sions among the research team to increase reliability of 
decisions made regarding categories and interpretations. 
The data were then revisited so that as many initial cate-
gories as possible could be synthesised into secondary 
themes. The analysis presented and quotations included 
are to give a flavour of the data, not to ‘prove’ the analysis.
results
survey findings
In total 238 people completed the survey; 102 NHSBSP 
attenders (SG), 103 symptomatic breast clinic attenders 
(CG) and 33 breast unit staff (HP). Other than the differ-
ences that would be anticipated between the groups due 
to the populations they were recruited from (age, employ-
ment status and breast treatment histories) smoking was 
significantly less frequent in the staff compared with the 
attender group (0% vs 10% current smokers, 88% vs 53% 
never smokers, p=0.012). An overview of the characteris-
tics of the participants in the three samples is shown in 
table 1.
screening (sg) and symptomatic clinic (Cg) samples
There were significantly more women under 50 and over 
70 years in the symptomatic clinic group than attended 
screening. In terms of knowledge of risk factors, there 
was little difference between the two groups (see table 2). 
Each group identified a mean of 1.8 risk factors (ranging 
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from 0 to 8). Obesity was identified as a risk factor by 
approximately 30% of participants, and smoking by 
almost 50% in each group whereas alcohol was listed by 
16% in the screening group, 23% in the symptomatic 
clinic group.
Alcohol
Personal alcohol consumption was reported by 60% 
of participants in the screening group and 73% in the 
clinic group. In those who did not drink alcohol, there 
was no difference between screening and clinic groups in 
Table 1 Demographics of survey participants
NHSBSP screening 
attenders
Symptomatic clinic 
attenders Staff Total
N (col %) N (col %) N (col %) N (col %)
Age group
  40 or under 1 (1.0) 16 (15.5) 8 (24.2) 25 (10.5)
  41 to 50 18 (17.6) 27 (26.2) 11 (33.3) 56 (23.5)
  51 to 60 50 (49.0) 23 (22.3) 13 (39.4) 86 (36.1)
  61 to 70 22 (21.6) 17 (16.5) 1 (3.0) 40 (16.8)
  71 and over 11 (10.8) 20 (19.4) 0 (0.0) 31 (13.0)
Relationship status
  Never married 12 (11.8) 13 (12.6) 7 (21.9) 32 (13.5)
  Married 65 (63.7) 61 (59.2) 20 (62.5) 146 (61.6)
  Separated 18 (17.6) 15 (14.6) 4 (12.5) 37 (15.6)
  Widowed 7 (6.9) 14 (13.6) 1 (3.1) 22 (9.3)
Employment status
  Working 60 (60.6) 49 (53.3) 33 (100.0) 142 (63.4)
  Retired 24 (24.2) 31 (33.7) 0 (0.0) 55 (24.6)
  Looking after the home or family 10 (10.1) 8 (8.7) 0 (0.0) 18 (8.0)
  Long-term sick or disabled 5 (5.1) 4 (4.3) 0 (0.0) 9 (4.0)
General health
  Good 79 (79.8) 71 (78.9) 30 (90.9) 180 (81.1)
  Fair 16 (16.2) 15 (16.7) 3 (9.1) 34 (15.3)
  Poor 4 (4.0) 4 (4.4) 0 (0.0) 8 (3.6)
Treatment history
  Attended screening 53 (67.9) 23 (31.9) 8 (66.7) 84 (51.9)
  Investigated for symptoms 23 (29.5) 24 (33.3) 4 (33.3) 51 (31.5)
  Treated for breast cancer 2 (2.6) 25 (34.7) 0 (0.0) 27 (16.7)
Body mass index group
  Healthy/underweight (<25 kg/m2) 32 (35.6) 35 (45.5) 15 (50.0) 82 (41.6)
  Overweight 37 (41.1) 19 (24.7) 9 (30.0) 65 (33.0)
  Obese (≥30 mg/m2) 21 (23.3) 23 (29.9) 6 (20.0) 50 (25.4)
Smoking status
  Current smoker 11 (10.9) 9 (9.8) 0 (0.0) 20 (8.8)
  Ex-smoker 32 (31.7) 33 (35.9) 4 (12.1) 69 (30.5)
  Never smoked 58 (57.4) 50 (54.3) 29 (87.9) 137 (60.6)
Alcohol status
  Has drunk alcohol in last 12/12 61 (60.4) 66 (73.3) 25 (75.8) 152 (67.9)
  Has not drunk alcohol in last 12/12 40 (39.6) 24 (26.7) 8 (24.4) 72 (32.1)
Total 102 103 33 238
NHSBSP, NHS Breast Screening Programme. 
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identifying alcohol as a risk factor for breast cancer (15% 
vs 16%). However, among those who drank alcohol, iden-
tifying this as a risk factor for breast cancer was signifi-
cantly more likely in the symptomatic group (35%) than 
those attending screening (4%) (X2 12.7, p=0.0004). See 
figure 1
Only 88/152 (57.9%) participants who drank alcohol 
stated that they knew how to estimate the alcohol content 
in drinks, and of these 72%, 55%, 24% and 24% correctly 
identified the number of units in a standard glass of wine, 
pint of beer, litre of cider and bottle of spirits respectively, 
out of a choice of four options for each one. Overall 
in both SG and CG there was a significant association 
between identifying alcohol as a risk factor for breast 
cancer and personal alcohol consumption (25.2% in those 
who drink alcohol vs 10.9% in non-drinkers, p=0.031), as 
well as a positive association with being able to correctly 
identify the alcohol content of drinks. Of those who got 
none of the four drink units correct, 86.2% also did not 
identify alcohol as a risk factor compared with 13.8% who 
did identify alcohol as a risk factor (p=0.01), suggesting 
that increased awareness about alcohol is associated with 
the knowledge necessary (if not sufficient) to facilitate 
behaviour change (see table 3).
Figure 1 Identification of alcohol as a risk factor for breast 
cancer by drinking status in screening and clinic attenders.
Table 2 Identification of risk factors (RF) for breast cancer in survey participants
NHSBSP screening 
attenders
Symptomatic clinic 
attenders Total
Statistics N (col %) N (col %) N (col %)
Identified at least one RF Pearson
χ2 (1) 0.0164
p=0.898
  No 23 (22.5) 24 (23.3) 47 (22.9)
  Yes 79 (77.5) 79 (76.7) 158 (77.1)
Modifiable RF identified Pearson
χ2 (1) 0.0391
p=0.843
  Yes 65 (63.7) 67 (65.0) 132 (64.4)
  No 37 (36.3) 36 (35.0) 73 (35.6)
Non-modifiable RF identified Pearson
χ2 (1) 0.8197
p=0.365
  Yes 51 (50.0) 45 (43.7) 96 (46.8)
  No 51 (50.0) 58 (56.3) 109 (53.2)
Obesity identified as RF Pearson
χ2 (1) 0.0647
p=0.799
  Yes 31 (30.4) 33 (32.0) 64 (31.2)
  No 71 (69.6) 70 (68.0) 141 (68.8)
Alcohol identified as RF Pearson
χ2 (1) 1.8921
p=0.169
  Yes 16 (15.7) 24 (23.3) 40 (19.5)
  No 86 (84.3) 79 (76.7) 165 (80.5)
Lifestyle identified as RF Pearson
χ2 (1) 0.3280
p=0.567
  Yes 8 (7.8) 6 (5.8) 14 (6.8)
  No 94 (92.2) 97 (94.2) 191 (93.2)
Hormone medications identified as RF Pearson
χ2 (1) 0.3282
p=0.567
  Yes 13 (12.7) 16 (15.5) 29 (14.1)
  No 89 (87.3) 87 (84.5) 176 (85.9)
Smoking identified as RF Pearson
χ2 (1) 0.1194
p=0.730
  Yes 49 (48.0) 47 (45.6) 96 (46.8)
  No 53 (52.0) 56 (54.4) 109 (53.2)
Total 102 (100.0) 103 (100.0) 205 (100.0)
RF, risk factor; NHSBSP, NHS Breast Screening Programme. 
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Obesity
In terms of BMI, based on self-reported height and 
weight, (see table 1) a minority of each group (36% in 
SG and 46% in CG group) could be classified within the 
healthy/underweight range, while 23% of SG (and 30% 
of the CG) met the criteria for being obese.27 Approx-
imately one-third of each group identified obesity as a 
risk factor for breast cancer, however women whose BMI 
placed them in the obese category, were significantly 
less likely to list obesity as a risk factor in the unadjusted 
logistic regression model (OR = 0.365, CI 0.16 to 0.834, 
p<0.05) with no difference between screening and symp-
tomatic groups.
Potential impact of adding prevention information
The response to adding a ‘5 min cancer prevention informa-
tion session’ to either the SG or CG was similar in both 
groups 60/197 (30.5%) said it would make them more 
likely to attend and 137/197 (69.5%) said it would make 
no difference to their attendance. No one marked the 
option that it would make them less likely to attend. 
Potential disadvantages of adding a cancer prevention 
session were identified by 28% of the SG and 40% of 
CG, with time, additional use of resources and potential 
cause for anxiety cited as the main concerns. In terms of 
preference for how this might be delivered, 31% stated 
they would prefer this to be by an electronic device, 26% 
by post, 40% by a trained nurse and 18% by a trained 
volunteer.
Health professional sample
Thirty-three health professionals (HPs) participated and 
key findings are summarised in table 1. Seventy-three 
per cent of the HP sample named at least one risk factor 
for developing breast cancer. Obesity was identified by 
19/33 (58%) and alcohol consumption was identified 
by 17/33 (52%)HPs. 45% (15/33) stated they knew how 
much alcohol was in a drink, and correct answers (out of 
a choice of four) were given by 21% to 61% of the sample 
for four commonly consumed drinks. Similarly to the SG 
and CG samples the majority of staff (22/33- 67%) felt 
that adding a cancer prevention session would make no 
difference to attendance, but less (5/33- 15%) thought 
it would encourage attendance and one HP thought it 
would discourage people from attending. A far higher 
percentage of the HP group than the CG/SG partici-
pants listed potential disadvantages of adding a cancer 
prevention session (82%). In addition to time, use of 
additional resources and potential cause for anxiety the 
staff group also mentioned contributing to ‘the worried 
well’ culture, time inefficiencies and fears about it being 
seen as ‘blaming’ or patronising’ as potential disadvan-
tages. In terms of preferred method of delivery 52% 
stated they would prefer this to be by an electronic device, 
30% by post, 18% by a trained nurse and 9% by a trained 
volunteer.
Qualitative findings
In accordance with the open ended focus group ques-
tions (see online supplementary appendix C) themed 
around the potential introduction of cancer risk messages 
to symptomatic clinics, what follows are the principle 
emergent themes from the focus group discussions and 
interviews.
trust, knowledge and uncertainty in relation to cancer risk 
factors
In line with the results of the main survey women showed 
little knowledge of alcohol as a risk for breast cancer, they 
also demonstrated considerable uncertainty about which 
sources of information they could trust. Women’s knowl-
edge of breast cancer tended to be based on their own 
experiences or stories told by others they knew, which in 
turn could encourage them to find out more. In focus 
Table 3 Identification of alcohol as risk factor by own alcohol status and knowledge in survey participants
Identified alcohol as a risk factor
Statistics
No Yes Total
N (row %) N (row %) N (row %)
Has drunk alcohol in last 12 months 95 (74.8) 32 (25.2) 127 (100.0) Pearson
χ2 (2) 6.9734
p=0.031
Has not drunk alcohol in last 12 months 57 (89.1) 7 (10.9) 64 (100.0)
Missing 13 (92.9) 1 (7.1) 14 (100.0)
Knows how to find alcohol content (if drinks) Pearson
χ2 (2) 10.2683 
p=0.006
  Yes 57 (70.4) 24 (29.6) 81 (100.0)
  No 40 (81.6) 9 (18.4) 49 (100.0)
  Missing/does not drink 68 (90.7) 7 (9.3) 75 (100.0)
Able to give units in any of four drinks Pearson
χ2 (2) 9.1821 
p=0.01
  None correct 100 (86.2) 16 (13.8) 116 (100.0)
  One or two/four correct 52 (77.6) 15 (22.4) 67 (100.0)
  Three or four/four correct 13 (60.0) 9 (40.9) 22 (100.0)
Total 165 40 205
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groups they exchanged stories and talked of what they had 
learnt; they appeared to trust this type of first-hand infor-
mation and started engaging with it by asking questions.
The conversations suggested a real lack of knowledge 
about how managing alcohol consumption fitted into a 
healthy lifestyle, or even how to talk about it: how much 
was safe; whether it was a risk at all; how many units were 
in a measure and understanding different sized drinks 
and strengths of alcohol. 
I mean a glass of wine’s… it’s a bit like a cup of tea… 
a glass of wine used to be like that, [hand movement 
demonstrates small size] now it’s like that ([hand 
movement demonstrates bigger size] when you ask 
just for a glass they vary enormously (FG4, p1).
Both women and staff recognised a need to under-
stand more about lower risk alcohol consumption specif-
ically relative to volumes of drinks consumed. Women’s 
motivations, understanding and rationalisation for their 
own alcohol consumption were varied and complex and 
perhaps reflect the varied cultural values, symbolic value 
and messages about alcohol represented in today’s social 
environment.
Women’s expectations of the role of health profes-
sionals in providing health education were also apparent 
here; they said they were happy for staff to advise them in 
breast screening clinics, hinting at a certain passivity in 
their own role in seeking/receiving alcohol information 
of this kind.
I think having any kind of information about it. I 
mean I haven’t heard anything about breast cancer at 
all. Not from my GP – no one’s mentioned it once. So 
I think it’s just having any kind of information at all 
would be a good place to start (FG4, p.8).
Both women and staff wanted consistent, evidence-
based facts about alcohol consumption, and specific risks 
related to breast, rather than other forms of cancer 
…People aren’t aware exactly how much they drink 
and also are surprised when they find out that alco-
hol is a risk factor for breast cancer (iv7, p3).
Participants felt there were many mixed messages about 
the risks of alcohol consumption, and wanted clear infor-
mation from a trusted source
it’s been marketed in such a way that, particularly 
with wine, that it’s good for you, in a way (iv5, p1).
Both staff and women saw concrete, evidence-based 
information as a necessity in a field where there is an 
overwhelming amount of uncertain information, which 
can cause anxiety.
However, despite appearing to value and engage with 
information gained from peers in focus groups, women 
talked of finding it hard to know how to view conflicting 
information from media, hearsay and their own expe-
riences. Women who talked of knowledge gained from 
lived experiences
I had it (breast cancer) 10 years ago. I don’t drink, I 
don’t smoke, and I still got it (FG4, p6)
had views that were seemingly less flexible and demon-
strated a lack of trust in ‘evidence based’ preventative 
information.
Staff echoed this uncertainty, highlighting their own 
and women’s confusion; they reported needing evidence 
about alcohol consumption and its specific links to breast 
cancer to feel more confident advising patients. Staff also 
displayed their own relatively low levels of literacy around 
alcohol in relation to breast cancer when talking about 
what they felt the content of preventative information 
should be. 
…the whole idea of trying to prevent cancer through 
lifestyle seems like it’s quite in its early stages…it’s not 
just the public that we need to spread the word to but 
it’s the healthcare professionals too because people 
are not really aware of it (iv2, p3).
Health professionals were fearful of offering false 
advice, again underlining their mixed views about the 
legitimacy of including preventative information in their 
role as health professionals and a strong concern
you just have to be careful you don’t put women off 
coming to screening… (iv8, p2),
yet women did not mention this as an issue, confirming 
the survey results presented above; rather that they 
wanted more opportunities to access information.
Staff also underlined their own need for training about 
levels of alcohol consumption and its bearing on breast 
cancer to improve their confidence delivering advice to 
patients.
Lack of time to engage with information was also a 
factor for women - they highlighted the need for succinct, 
universally appealing information that would engage 
across different groups in society. In a similar vein to the 
pink ribbon used for fundraising by breast cancer chari-
ties, staff suggested the idea of a symbol to use to catch 
women’s attention for prevention information.
the need for cultural change and individualised health 
messages
Both staff and women recognised a need for a wider 
cultural change before fully accepting the need to accept, 
act on and acknowledge alcohol as a modifiable risk for 
breast cancer.
I think as a nation we are not very honest about the 
harms of alcohol, and that goes across the board in 
terms of doctors and nurses as well (iv3, p2).
There appeared to be an unacknowledged ‘collusion 
of denial’ where staff and women avoided being proac-
tive in discussing alcohol as part of the dialogue around 
preventing breast cancer
I mean when is the best time for health promotion, I 
don’t know (iv4, p1).
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This suggests a challenge of dealing with alcohol as a 
risk for breast cancer on both sides, where women seemed 
to assume staff would tell them about risks that are impor-
tant and where staff would not ask women about their 
alcohol intake as they did not see it as part of their role.
Staff agreed that breast screening appointments could 
be ideal opportunities for preventative information
because you’ve already got yourself a self-selecting 
audience, people who feel it’s important enough to 
turn up(iv4, p2),
though did not see it as part of their role to deliver this 
information.
A key motivator for women appears to be whether a risk 
factor applies to them specifically
If you don’t own it, you’re not going to act on it are 
you? (FG3, p25).
In order to make informed choices about how to 
prevent breast cancer they reported wanting personal-
ised information in order to address the risks they knew 
about, and if it was meaningful to them, they seemed 
more motivated to make the changes. Confusion between 
relative risks of individual risk factors, population based 
risk factors and definite ‘causes’ were common.
Any rationale given for changes specifically to prevent 
breast cancer was primarily from women with lived expe-
rience of breast cancer (themselves or a close family 
member). They had either been advised by health profes-
sionals to make changes, or made aware by their affected 
family member:
I’ve got it on both sides of my family, …I…check what 
I eat….and I don’t drink a lot anyway (FG2);
they seldom talked of changes to alcohol consumption.
Overall, women with a family history of breast cancer 
reported being less inclined to make lifestyle changes, 
especially if relatives had adopted healthy lifestyles and 
had still got breast cancer, re-enforcing a more fatalistic 
view
my GP’s told me of various risk factors but then it 
happened to my mum anyway. So I shrug my shoul-
ders (FG4, p5) and there’s certain lifestyle things I 
can do but then I have, like, this little thing on my 
shoulder going ‘well it didn’t make any difference for 
my mum (FG5, p4).
Women suggested the use of humour as a way of making 
breast cancer prevention information more engaging and 
accessible 
…There should be more discussion between mothers 
and daughters … like fathers and sons. . ‘have you 
checked your balls son?’ [laughter] There should be 
a light-heartedness about it rather than it being you 
know when you see these adverts and it’s all tears … 
(FG4, p33),
although this was in the context of self-examination 
rather than addressing alcohol consumption.
tensions in discussing alcohol consumption as part of breast 
cancer prevention
In sharp contrast to the discussions of women in the focus 
groups, a common theme that ran through the interviews 
with staff was an ambivalence about discussing alcohol use 
with women who came to screening or symptomatic breast 
appointments. This ambivalence appeared to reflect a 
number of underlying processes. These are described 
here in preliminary form, but will require much greater 
exploration in future research (See figure 2).
Perceptions of responsibility
Staff recognised that prevention and health promotion 
was important, but did not see it as their role. Alcohol use 
was described as
the last thing (staff) would discuss with patients (iv1).
There was a certain sensitivity and worry about raising 
the topic.
People don’t like to think they’re being lectured to, 
patronised… it’s quite a careful balance…, between 
imparting useful information in a way that people are 
going to be receptive to or people feeling that you’re 
sort of ‘nanny stating’ them (iv8, p2).
There were also concerns about giving advice based on 
population risk and the inherent uncertainties between 
cause and effect that this contains
they might do (what is suggested)… they think 
they’ve done everything right and then they still get 
breast cancer (iv2, p2).
Staff agreed with the idea of health promotion, in 
principle
…it is important but maybe not essential"(iv8, p1),
but often felt the responsibility did not lie with them (as 
also shown in the survey results). This seemed connected 
with seeing themselves responsible for diagnosis and treat-
ment rather than prevention. There was ambivalence as 
to whether it was their role to encourage patients to take 
a preventative approach, by advising about lifestyle risk 
factors
I don’t really think it’s our role to do that(iv7, p3).
This tension between reactive and preventative health 
roles may be a barrier to integrating health prevention 
within already established screening and treatment 
services as part of a cancer prevention culture.
We’re very good at just focusing on the disease and 
not telling the patient what they can do to help (iv6, 
p1).
There was also a suggestion that different competencies 
may be required to fulfil the role:
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for those of us that are trained in symptom control 
or diagnostic activities, to be a health promoter is a 
very, very different kettle of fish and a very different 
training I would imagine (iv4, p1).
Women however did not appear to make this differen-
tiation within the health professional role, and saw them 
all as a trusted sources of advice.
I definitely think the preventative line you’re going 
down is far better than the reactive system we have at 
the moment (woman, FG4, p24).
A cultural mind-set underlying alcohol was considered 
to be a key barrier to acceptance of it as a modifiable risk 
factor for breast cancer
I can’t quite see…, a bottle of Lanson Champagne, 
saying on the bottle, you know this is a killer, don’t - 
don’t drink [laughter] (FG4, p4).
With one exception, there was difficulty in talking 
about alcohol use except as a significant problem for a 
minority of people 
it would be important to reinforce the idea that a lot 
of people drink too much that aren’t alcoholics and 
highlight the fact that it’s very normal (iv3, p1),
The need for a cultural shift in attitudes to alcohol-re-
lated behaviour as well as towards making preventative 
lifestyle choices was acknowledged in order to make 
conversations around alcohol and health less problematic.
I think undoubtedly people will bring their own prej-
udices to wherever they are, and clearly, people don’t 
like to feel hypocritical either do they, so I think the 
best bet is to try and be honest to people(iv8, p1).
Stigma of breast cancer and alcohol
Avoidance of risks was one way women reported gaining 
control over getting cancer, but this also related to feel-
ings of guilt if they saw it as their fault for not avoiding 
something
You think what might I have done that’s caused this? 
(FG2, p33).
If a risk of cancer was seen as genetic then women 
tended to feel they were immune from responsibility 
or blame for not making healthy lifestyle choices. One 
woman alluded to the judgement that might be made 
about someone with breast cancer
I just think [of them as] someone who’s got it wrong 
somewhere along the line. But then you’ve got – you 
know – genes that - that get passed on from your fam-
ily, so then I’d be wrong in that instance (FG4, p1).
This provokes questions around women’s feelings of 
guilt and blame for making the ‘right’ and ‘wrong’ life-
style choices and also show how stigma can exist even 
in groups of women who have experienced cancer 
themselves.
Figure 2 Ideas map: engaging with alcohol as a risk factor for breast cancer.
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DisCussiOn
This study demonstrates the potential acceptability 
and need for the development of a contextualised ABI 
as part of encouraging a cancer prevention culture in 
breast health settings. The qualitative findings illuminate 
where women’s and staff views meet and diverge. This will 
inform the development of an appropriate intervention 
that engages women with alcohol information, giving 
them feedback about their alcohol consumption in a 
breast health context. This can be used as an opportu-
nity to improve awareness of alcohol as a risk factor for 
breast cancer, and improve skills in monitoring alcohol 
consumption.
Although the exact mechanism by which alcohol acts 
to promote carcinogenesis is unclear, epidemiological 
evidence that alcohol is a significant and modifiable dose 
dependent risk factor for breast cancer is now widely 
accepted by the scientific community. However, our 
data indicate that this information is not known by the 
majority of women attending breast screening and symp-
tomatic clinics. These results are similar to others which 
have examined awareness of alcohol as a risk factor for 
breast cancer,14 and also studies demonstrating low levels 
of knowledge about alcohol content of drinks in the 
public and health professionals
This is particularly important as recent changes to UK 
Chief Medical Officers’ low risk drinking guidelines15 
aimed to publicise the concept that there is no safe level 
of drinking and highlighted the potential long-term 
risks associated with alcohol intake even at low levels, 
including the development of certain cancers, including 
breast cancer.
The Health Survey for England (2014) indicates that 
almost 80% of women had drunk alcohol at some point 
during the previous year; the percentage of women 
drinking over 14 (UK) units per week was highest in the 
45 to 54 year (20%) and 55 to 64 year (22%) age groups 
and the proportion of people drinking at increased-risk-
levels was greatest in the highest income groups.8 Home 
drinking is an embedded social practice, which may be 
resistant to change,28 and this normalisation of alcohol 
use by health professionals may account for some of the 
ambivalence they have to discuss alcohol consumption 
as a risk factor for breast cancer with patients. However, 
it is also important to acknowledge the ‘alcohol harm 
paradox’ which shows that although people in lower 
social classes drink less, they have worse alcohol related 
morbidity.29 This is associated with a clustering of other 
factors in more deprived groups, such as obesity, smoking 
and poor diet and exercise, which are also relevant modi-
fiable factors for breast cancer prevention, and may 
have an impact on how they receive and act on health 
messages.23 However, the social gradient is reversed in 
terms of breast cancer incidence,30 31 suggesting that any 
intervention targeted at reducing alcohol consumption 
should have benefits across the female population and 
will not worsen any health inequalities.
Both staff and clinic attendees showed ambivalence 
about discussing alcohol, concerned about it being 
taken as stigmatising or blaming women, demonstrating 
a wider social ambivalence about our relationship with 
alcohol. However, this study and the predicting risk of 
cancer at screening (PROCAS) clinical trial, which is 
exploring the potential to produce personalised breast 
cancer risk assessments, have both confirmed that it is 
feasible for women to interact with a brief and unsuper-
vised health survey while attending routine screening 
appointments, despite the short appointment times 
provided in this setting.2 Most importantly, our data 
confirm that women would not be put off attending 
breast screening or clinic appointments if they were 
aware they would receive some cancer prevention 
education and many in fact suggesting that they would 
welcome this intervention with over 30% indicating 
that this would make them more likely to attend their 
appointment. Data collected in this study have been 
used to inform a logic model which will underpin the 
development of an intervention prototype.
The effectiveness of ABIs to reduce alcohol intake 
in people drinking at non-dependent levels has been 
investigated extensively, with good evidence for effec-
tiveness.32 33 While historically, ABIs have been provided 
by professionals, there are now increasing numbers of 
online tools which aim to provide screening, monitoring 
and support.34 There is some evidence that women and 
young people may find this a more attractive option than 
a face-to-face session.35 36 There is also evidence that 
simply answering questions on alcohol intake can result 
in changing subsequent self-reported behaviour.37
In 2008, Demark-Wahnefried et al published guide-
lines encouraging physicians to use ‘teachable moments’ 
to provide patients with lifestyle advice aimed at cancer 
prevention, regardless of the patient’s motivation to 
receive the message.38 It is interesting to note that while 
it has become routine practice to assess patients in breast 
clinics for a possible inherited susceptibility to breast 
cancer and refer on for family history or genetics inves-
tigation, there is currently no equivalent pathway for 
patients who have potentially significant modifiable life-
style risk factors, including alcohol use.
strengths and limitations
The study is limited in that it was carried out in a single 
centre and was cross-sectional in nature. Given the lack of 
research in this area, a survey utilising a range of response 
modes, including free text responses, was used to explore 
knowledge of alcohol as a risk factor for breast cancer 
in the absence of a validated tool. However, a signifi-
cant strength of this study is the use of mixed methods 
to explore in greater depth the findings from the survey, 
to better understand the ambivalence that attendees 
and staff have to discuss alcohol use as part of cancer 
prevention.
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COnClusiOn
This study confirms that knowledge of alcohol as a modi-
fiable risk factor for breast cancer is low among women 
attending symptomatic breast clinics or routine NHSBSP 
mammograms. A lack of literacy regarding the alcohol 
content of commonly consumed drinks indicates that 
many women are not well equipped to assess their own 
alcohol intake. However, many women participating in 
this study reacted positively to the suggestion of adding 
information on cancer prevention, in general, to NHS 
breast screening or clinic attendances, although there 
was ambivalence by staff to delivering it. Full utilisation 
of these ‘ teachable   moments ’  will require education 
of healthcare professionals, as well as a wider cultural 
change around alcohol use. Further research is also 
required to understand how best to embed a prevention 
culture, which includes giving clear non-judgemental 
information about the relative risks of alcohol consump-
tion, within current health systems.
Please include Figure legends/captions at the end of 
your main manuscript
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